Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Agathos Biologics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Agathos Biologics

Agathos Biologics

Pre-Seed

Agathos Biologics: A biotech firm innovating transformative science with strong ethics.

HQ
Fargo, ND, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Founded with a commitment to ethical innovation, Agathos Biologics is a biotechnology company focused on developing transformative scientific solutions. The company's core mission is to advance "Good Science without compromise," ensuring that their work adheres to high ethical standards. Agathos Biologics offers a range of services including custom AAV (Adeno-Associated Virus) production, analytical services, and proprietary cell lines like AE1-BHK. Their market focus spans various sectors in biotechnology, aiming to provide cutting-edge solutions for complex biological challenges.

Agathos Biologics has garnered attention for its strong ethical framework and impactful scientific contributions. The management team comprises experienced professionals dedicated to fostering innovation with integrity. Notable achievements include the development of advanced cell lines and custom viral vectors that have significant implications for gene therapy and other medical applications. The company's emphasis on ethical practices has set a benchmark in the biotech industry, promoting responsible science that aims to improve global health outcomes.

Agathos Biologics - Similar Companies

Agile Sciences logo

Agile Sciences

agilesci.com

AthemBio logo

AthemBio

athembio.com

Aavogen logo

Aavogen

aavogen.com

AgThera logo

AgThera

agthera.com

Synvivia logo

Synvivia

synvivia.com

Celltheon logo

Celltheon

celltheon.com

Gift of Life Biologics logo

Gift of Life Biologics

Agtc logo

Agtc

beacontx.com

PackGene Biotech logo

PackGene Biotech

packgene.com

Biotech Holdings logo

Biotech Holdings

CasTag Biosciences logo

CasTag Biosciences

Ichosia Biotechnology logo

Ichosia Biotechnology

Virogenomics logo

Virogenomics

virogenomics.com

64x Bio logo

64x Bio

64xbio.com

ExpressCells logo

ExpressCells

Agathos Biologics - Quick Facts

Who are Agathos Biologics' competitors?

Companies similar to Agathos Biologics include Agile Sciences, AthemBio, Aavogen and AgThera.

When was Agathos Biologics founded?

Agathos Biologics was founded in 2016.

Where is Agathos Biologics' headquarters located?

Agathos Biologics' headquarters is located in Fargo, ND, US.

When was Agathos Biologics' last funding round?

Agathos Biologics' most recent funding round was for $900k (USD) in August 2021.

How much has Agathos Biologics raised to-date?

As of Aug 30, 2021, Agathos Biologics has raised a total of $900k (USD).

How many employees does Agathos Biologics have?

Agathos Biologics has 11 employees as of Feb 4, 2024.

Agathos Biologics - Classification

Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Services
Customer
  • Enterprise
Main Product
  • AAV
  • Cell Lines
Tags
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software